vialroom

#cagrilintide 2026-02-03

Tuesday22 messages6 participantstimes are UTC
Highlights from this day
  • factory_direct_fi — genuine question went slower because the first step gave me two rough days and i took that as information, i could be wrong 21:35
  • nausea_window — two PeptideMeter results on the same QYB lot came back 97.4 and 99.4, closer than i expected 22:05
  • nausea_window — sorry to jump in held at 1 for 7 months on monotherapy before i touched it again 22:28
  • nausea_window — weekly for me, same day every week, no reason beyond habit 22:30
  • surpass_two — whats the recon people use, 5 in 2.5ml 23:05
ST

dosing them on different days made no difference i could detect, thats just me

FD

genuine question went slower because the first step gave me two rough days and i took that as information, i could be wrong

is the slower titration because of nausea or something else

amylin not glp-1

2 in 0.5ml gives 2mg/ml which is what i use, purely because the units come out round

did anyone add this to an existing retatrutide dose rather than starting both

NW

two PeptideMeter results on the same QYB lot came back 97.4 and 99.4, closer than i expected

AA

monotherapy did work for me, just slower and smaller than i expected

follow up i keep the two on separate days so if something goes wrong i have a chance of knowing which

FA

nobody should copy my schedule, im describing it because people asked what a slow ramp looks like

NW

monotherapy was underwhelming for me and i say that as someone who wanted it to work, n of 1 obviously

weekly for me, same day every week, no reason beyond habit

🎉1🧊1⚠️4
AA

is there a reason people titrate this over more weeks than the others

LL

its an amylin analogue, different receptor family, so treating it as another GLP-1 is the first mistake

ST

CagriSema is cagrilintide with semaglutide and REDEFINE is the trial programme around it